Gary Bond in Oklahoma City, Oklahoma

Home Oklahoma Oklahoma City

Gary Bond has Nephrology as his primary medical specialty. Their primary office is: 3300 Nw Expressway in Oklahoma City, Oklahoma. There is an additional office location, for a total of two, for Gary Bond that can be viewed further down.

They're a part of the: Integris Ambulatory Care Corporation medical group which has around 383 members. You can call their office at 405-949-3141 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Oklahoma College Of Medicine and graduated in 1988 (around 36 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Gary D Bond Office Phone and Directions

Gary Bond
Integris Ambulatory Care Corporation
3300 Nw Expressway
Oklahoma City, Oklahoma 73112
405-949-3141

Patient Ratings
Please rate your experience with Gary Bond below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 405-949-3141

Enter a starting address:

Healthcare Info for Gary Bond

Medical School: University Of Oklahoma College Of Medicine
Graduation Year: 1988
The Primary Medical Specialty for Gary Bond is listed as: Nephrology
Approximate Years of Experience: 36
PAC (PECOS ID)#: 2961439237
NPI #: 1053316125
NPI Created On: 06/16/2005
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 207RN0300X
License Number:
16974
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Manual urinalysis test with examination using microscope
Hemodialysis procedure with one physician evaluation
Dialysis services (4 or more physician visits per month), patient 20 years of age and older
Dialysis services (2-3 physician visits per month), patient 20 years of age and older
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Physician telephone patient service, 11-20 minutes of medical discussion
Physician telephone patient service, 21-30 minutes of medical discussion
Injection, epoetin alfa, (for non-esrd use), 1000 units

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 797081447

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: KRYSTEXXA

Name of Drug #1: KRYSTEXXA

Open Associated Drug #1: 75987-080-10

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 797081453

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: KRYSTEXXA

Name of Drug #1: KRYSTEXXA

Open Associated Drug #1: 75987-080-10

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802127363

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: BENLYSTA

Open Associated Drug #1: 49401-101-01

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802586415

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: BENLYSTA

Open Associated Drug #1: 49401-101-01

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802773203

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: BENLYSTA

Open Associated Drug #1: 49401-101-01

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 827741631

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEPHROLOGY

Name of Drug #1: RAYALDEE

Open Associated Drug #1: 70301-1001-1

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 816099253

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hyperkalemia

Name of Drug #1: Veltassa

Open Associated Drug #1: 53436-084-30

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 816104767

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hyperkalemia

Name of Drug #1: Veltassa

Open Associated Drug #1: 53436-084-30

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 816109835

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hyperkalemia

Name of Drug #1: Veltassa

Open Associated Drug #1: 53436-084-30

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 816120519

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hyperkalemia

Name of Drug #1: Veltassa

Open Associated Drug #1: 53436-084-30

Additional Office Locations

1. Kidney Specialists Of Central Oklahoma, Pc
3366 Nw Expressway
Oklahoma City, OK 73112
Suite 550
Group Members: 17

Phone: 405-949-3141

Enter a starting address:

Nephrology Professionals in Oklahoma City

1.
Narisorn Atsava-svate

3400 Nw 56th St
Oklahoma-city, OK
Zuhdi Transplant Physicians

2.
Tirunelveli Venkataraman MD

1110 N Classen Blvd
Oklahoma-city, OK

3.
Ikuyo Yamaguchi MD

1200 Childrens Ave
Oklahoma-city, OK
Ou Health Partners Inc

4.
Ikuyo Yamaguchi MD

900 Ne 10th St
Oklahoma-city, OK
Ou Health Partners Inc

5.
Kerry Owens MD

3400 Nw Expressway
Oklahoma-city, OK

6.
Laura Rankin

3366 Nw Expressway
Oklahoma-city, OK
Kidney Specialists Of Central Oklahoma, Pc

Providers in Integris Ambulatory Care Corporation

1.Haley Adams

115 W 13th St
Grove Ok 74344-3224
Integris Ambulatory Care Corporation
General Surgery

2.Bilal Ahmad

4301 S Western Ave
Oklahoma City Ok 73109-3411
Integris Ambulatory Care Corporation
Hematology/oncology

3.Mohsin Ahmad

700 24th Ave Nw
Norman Ok 73069-6232
Integris Ambulatory Care Corporation
Family Practice

4.Mohsin Ahmad

3330 Nw 56th St
Oklahoma City Ok 73112-4426
Integris Ambulatory Care Corporation
Family Practice

5.Mohsin Ahmad

3400 Nw Expressway
Oklahoma City Ok 73112-4492
Integris Ambulatory Care Corporation
Family Practice

6.Shoaib Ahmad

3300 Nw Expressway
Oklahoma City Ok 73112-4418
Integris Ambulatory Care Corporation
Pulmonary Disease

View all 383 members of Integris Ambulatory Care Corporation medical group